CAPLIPOINT - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

IntraDay Trade Rating: 3.8

💊 Intraday Snapshot – Caplin Point Laboratories Ltd. (CAPLIPOINT)

Caplin Point presents a solid backdrop for low-risk, technical-based intraday trading, especially with its near-zero debt, strong fundamentals, and price action hovering just above key moving averages. However, volume is currently muted, so early-session confirmation is crucial.

📊 Technical Signals

Price @ ₹2,086 is above DMA 50 (₹2,061) and DMA 200 (₹1,987) → bullish support zone.

MACD (4.04) → positive crossover; momentum buildup potential.

RSI (52.6) → slightly bullish, hints at further upside.

Volume (41.9K) < Avg Vol (54.4K) → needs pickup for conviction.

Price is ~21% below 52W High (₹2,641) → room to rally if intraday breakout forms.

💼 Fundamental Highlights

Indicator Value Interpretation

ROE / ROCE 21.7% / 25.8% Strong capital efficiency

Debt-to-Equity 0.00 Clean balance sheet – no debt

PAT QoQ Growth +2.9% Stable earnings

PEG Ratio 1.38 Fair valuation relative to growth

EPS vs Industry PE ₹70.6 vs 29.6 Attractive earnings, moderate P/E

FII/DII Holding Change +0.43% / +0.22% Institutional interest observed

🎯 Intraday Strategy

✅ New Entry Plan

Buy Zone: ₹2,085–₹2,090 (preferably post VWAP reclaim or MACD histogram expansion)

Profit Target

Primary: ₹2,099–₹2,104

Extended: ₹2,110 if volume exceeds 50K by mid-session

Stop Loss: ₹2,073 (below recent support pivot)

🕒 Exit Strategy – If Already Holding

Consider exiting if

Price doesn’t breach ₹2,099–2,100 by 12:45 PM IST

RSI stays flat or dips below 51.5

MACD slope starts narrowing post-11:30 AM

Volume remains below 45K into the second half of the session

Recommended Exit Window: 12:30–1:15 PM IST

🔎 Want help scanning similar low-debt, high ROCE pharma plays that align with intraday or swing trade setups? I can tee up a custom screener for you. Let’s optimize your radar.

Edit in a page